Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Iteos Therapeutics Inc
(NQ:
ITOS
)
8.500
+0.180 (+2.16%)
Streaming Delayed Price
Updated: 11:48 AM EST, Nov 25, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
139,452
Open
8.370
Bid (Size)
8.490 (2)
Ask (Size)
8.510 (1)
Prev. Close
8.320
Today's Range
8.220 - 8.590
52wk Range
7.540 - 18.75
Shares Outstanding
35,763,742
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
iTeos Reports Third Quarter 2024 Financial Results and Provides Business Updates
November 12, 2024
From
iTeos Therapeutics Inc.
Via
GlobeNewswire
iTeos Therapeutics to Highlight Inupadenant Preclinical, Translational, and Phase 2 A2A-005 Clinical Trial Data in 2L NSCLC at ESMO Immuno-Oncology Congress
October 24, 2024
From
iTeos Therapeutics Inc.
Via
GlobeNewswire
Performance
YTD
-26.66%
-26.66%
1 Month
-2.52%
-2.52%
3 Month
-52.70%
-52.70%
6 Month
-50.23%
-50.23%
1 Year
-7.81%
-7.81%
More News
Read More
The One-Minute Market Report - Sunday, Sept. 22
September 22, 2024
Via
Talk Markets
Sky Harbour Group, SolarEdge Technologies And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
September 17, 2024
Via
Benzinga
Nuvalent Flies On 'Multibillion-Dollar' Potential, While Iteos Crashes On Patient Deaths
September 16, 2024
Via
Investor's Business Daily
Topics
Death
Exposures
Death
Crude Oil Surges Over 1%; Instil Bio Shares Plunge
September 16, 2024
Via
Benzinga
Exposures
Fossil Fuels
iTeos Therapeutics, Upstart Holdings And Other Big Stocks Moving Lower In Monday's Pre-Market Session
September 16, 2024
Via
Benzinga
Why Exicure Shares Are Trading Higher By Over 49%; Here Are 20 Stocks Moving Premarket
September 16, 2024
Via
Benzinga
iTeos Announces Clinically Meaningful Objective Response Rate Observed at Every Dose in Follow-up Interim Analysis of GALAXIES Lung-201 Study of Belrestotug + Dostarlimab in First-Line, PD-L1 High Non-Small Cell Lung Cancer Patients
September 14, 2024
From
iTeos Therapeutics Inc.
Via
GlobeNewswire
iTeos to Participate in Upcoming Investor Conferences
August 28, 2024
From
iTeos Therapeutics Inc.
Via
GlobeNewswire
iTeos Therapeutics Announces Late-Breaking Oral Presentation of Phase 2 GALAXIES Lung-201 Interim Data at the European Society for Medical Oncology Congress 2024
August 20, 2024
From
iTeos Therapeutics Inc.
Via
GlobeNewswire
ITOS Stock Earnings: ITeos Therapeutics Beats EPS for Q2 2024
August 08, 2024
Via
InvestorPlace
iTeos Reports Second Quarter 2024 Financial Results and Provides Business Updates
August 08, 2024
From
iTeos Therapeutics Inc.
Via
GlobeNewswire
iTeos Therapeutics Announces Appointment of David Feltquate as Chief Medical Officer
August 05, 2024
From
iTeos Therapeutics Inc.
Via
GlobeNewswire
iTeos Announces First Patient Dosed in GALAXIES Lung-301 Phase 3 Study, Earning $35 Million in Milestones from GSK
July 08, 2024
From
iTeos Therapeutics Inc.
Via
GlobeNewswire
iTeos and GSK Initiate GALAXIES Lung-301 Phase 3 Study, Assessing Belrestotug and Dostarlimab in Previously Untreated, Unresectable Locally Advanced / Metastatic PD-L1 Selected Non-Small Cell Lung Cancer
June 17, 2024
From
iTeos Therapeutics Inc.
Via
GlobeNewswire
10 Health Care Stocks With Whale Alerts In Today's Session
May 28, 2024
Via
Benzinga
ITOS Stock Earnings: ITeos Therapeutics Beats EPS for Q1 2024
May 10, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's Intraday Session
May 10, 2024
Via
Benzinga
Why Diodes Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
May 10, 2024
Via
Benzinga
Genpact Posts Upbeat Earnings, Joins Groupon, Natera, Funko, CarGurus And Other Big Stocks Moving Higher On Friday
May 10, 2024
Via
Benzinga
Dow Jumps Over 100 Points; DNOW Posts Downbeat Earnings
May 10, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
iTeos Reports First Quarter 2024 Financial Results and Provides Business Updates
May 10, 2024
From
iTeos Therapeutics Inc.
Via
GlobeNewswire
iTeos Therapeutics Announces $120 Million Registered Direct Offering
May 10, 2024
From
iTeos Therapeutics Inc.
Via
GlobeNewswire
iTeos Presents EOS-984 Preclinical Data Demonstrating Restoration of T Cell Activity from Adenosine Suppression at the American Association for Cancer Research Annual Meeting 2024
April 07, 2024
From
iTeos Therapeutics Inc.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.